{"publication":"Heffron (2001)","year":2001,"randomized":"n.s.","control.type":"concurrent","comparison":"delayed CNI","IL2RA":"daclizumab","CNI":"tacrolimus","MMF":"yes","followup":12,"exp.AR.events":14,"exp.deaths":4,"exp.total":54,"cont.AR.events":23,"cont.deaths":4,"cont.total":47}
{"publication":"Washburn (2001)","year":2001,"randomized":"yes","control.type":"concurrent","comparison":"no/low steroids","IL2RA":"daclizumab","CNI":"tacrolimus","MMF":"yes","followup":18,"exp.AR.events":1,"exp.deaths":0,"exp.total":15,"cont.AR.events":1,"cont.deaths":1,"cont.total":15}
{"publication":"Neuhaus (2002)","year":2002,"randomized":"yes","control.type":"concurrent","comparison":"IL-2RA only","IL2RA":"basiliximab","CNI":"cyclosporine A","MMF":"no","followup":12,"exp.AR.events":74,"exp.SRR.events":34,"exp.deaths":25,"exp.total":188,"cont.AR.events":88,"cont.SRR.events":51,"cont.deaths":31,"cont.total":193}
{"publication":"Innocenti (2003)","year":2003,"randomized":"no","control.type":"concurrent","comparison":"IL-2RA only","IL2RA":"daclizumab","CNI":"cyclosporine A","MMF":"yes","exp.AR.events":7,"exp.deaths":0,"exp.total":24,"cont.AR.events":4,"cont.deaths":1,"cont.total":10}
{"publication":"Yan (2004)","year":2004,"randomized":"yes","control.type":"concurrent","comparison":"delayed CNI","IL2RA":"basiliximab","CNI":"cyclosporine A","MMF":"yes","followup":3,"exp.AR.events":3,"exp.SRR.events":0,"exp.total":24,"cont.AR.events":9,"cont.SRR.events":1,"cont.total":24}
{"publication":"Boillot (2005)","year":2005,"randomized":"yes","control.type":"concurrent","comparison":"no/low steroids","IL2RA":"daclizumab","CNI":"tacrolimus","MMF":"no","followup":3,"exp.AR.events":89,"exp.SRR.events":10,"exp.deaths":25,"exp.total":351,"cont.AR.events":92,"cont.SRR.events":22,"cont.deaths":20,"cont.total":347}
{"publication":"Fasola (2005)","year":2005,"randomized":"yes","control.type":"concurrent","comparison":"IL-2RA only","IL2RA":"daclizumab","CNI":"tacrolimus","MMF":"yes","followup":12,"exp.AR.events":13,"exp.deaths":4,"exp.total":46,"cont.AR.events":11,"cont.deaths":2,"cont.total":24}
{"publication":"Lin (2005)","year":2005,"randomized":"no","control.type":"concurrent","comparison":"delayed CNI","IL2RA":"basiliximab","CNI":"tacrolimus","MMF":"yes","followup":6,"exp.AR.events":3,"exp.deaths":0,"exp.total":27,"cont.AR.events":5,"cont.deaths":0,"cont.total":18}
{"publication":"Yoshida (2005)","year":2005,"randomized":"yes","control.type":"concurrent","comparison":"delayed CNI","IL2RA":"daclizumab","CNI":"tacrolimus","MMF":"yes","followup":12,"exp.AR.events":17,"exp.deaths":10,"exp.total":72,"cont.AR.events":21,"cont.deaths":5,"cont.total":76}
{"publication":"Lu (2006)","year":2006,"randomized":"n.s.","control.type":"concurrent","comparison":"IL-2RA only","IL2RA":"daclizumab","CNI":"tacrolimus","MMF":"yes","followup":6,"exp.AR.events":3,"exp.deaths":3,"exp.total":40,"cont.AR.events":3,"cont.deaths":2,"cont.total":27}
{"publication":"de Simone (2007)","year":2007,"randomized":"yes","control.type":"concurrent","comparison":"no/low steroids","IL2RA":"basiliximab","CNI":"cyclosporine A","MMF":"yes","followup":12,"exp.AR.events":17,"exp.deaths":7,"exp.total":95,"cont.AR.events":21,"cont.deaths":8,"cont.total":95}
{"publication":"Humar (2007)","year":2007,"randomized":"no","control.type":"historical","comparison":"no/low steroids","IL2RA":"basiliximab","CNI":"tacrolimus","MMF":"yes","followup":16,"exp.AR.events":9,"exp.SRR.events":0,"exp.deaths":10,"exp.total":83,"cont.AR.events":10,"cont.SRR.events":0,"cont.deaths":16,"cont.total":83}
{"publication":"Kato, cohort 1 (2007)","year":2007,"randomized":"yes","control.type":"concurrent","comparison":"no/low steroids","IL2RA":"daclizumab","CNI":"tacrolimus","MMF":"no","followup":12,"exp.AR.events":7,"exp.total":15,"cont.AR.events":9,"cont.total":16}
{"publication":"Kato, cohort 2 (2007)","year":2007,"randomized":"yes","control.type":"concurrent","comparison":"no/low steroids","IL2RA":"daclizumab","CNI":"tacrolimus","MMF":"yes","followup":12,"exp.AR.events":3,"exp.total":16,"cont.AR.events":8,"cont.total":23}
{"publication":"Klintmalm (2007)","year":2007,"randomized":"yes","control.type":"concurrent","comparison":"no/low steroids","IL2RA":"daclizumab","CNI":"tacrolimus","MMF":"yes","followup":12,"exp.AR.events":80,"exp.deaths":11,"exp.total":153,"cont.AR.events":46,"cont.deaths":8,"cont.total":79}
{"publication":"Schmeding (2007)","year":2007,"randomized":"yes","control.type":"concurrent","comparison":"IL-2RA only","IL2RA":"basiliximab","CNI":"tacrolimus","MMF":"no","exp.AR.events":29,"exp.SRR.events":6,"exp.deaths":4,"exp.total":51,"cont.AR.events":25,"cont.SRR.events":3,"cont.deaths":3,"cont.total":48}
{"publication":"Lupo (2008)","year":2008,"randomized":"yes","control.type":"concurrent","comparison":"no/low steroids","IL2RA":"basiliximab","CNI":"cyclosporine A","MMF":"no","followup":22,"exp.AR.events":4,"exp.deaths":4,"exp.total":26,"cont.AR.events":6,"cont.deaths":8,"cont.total":21}
{"publication":"Neuberger (2009)","year":2009,"randomized":"yes","control.type":"concurrent","comparison":"delayed CNI","IL2RA":"daclizumab","CNI":"tacrolimus","MMF":"yes","followup":12,"exp.AR.events":28,"exp.deaths":11,"exp.total":168,"cont.AR.events":45,"cont.deaths":19,"cont.total":168}
{"publication":"Calmus (2010)","year":2010,"randomized":"yes","control.type":"concurrent","comparison":"delayed CNI","IL2RA":"daclizumab","CNI":"tacrolimus","MMF":"yes","followup":24,"exp.AR.events":23,"exp.SRR.events":1,"exp.deaths":9,"exp.total":98,"cont.AR.events":24,"cont.SRR.events":3,"cont.deaths":6,"cont.total":101}